FGF23 and neoplasm: Furthermore, FGF23 possibly contributes to a bone-like microenvironment in phosphaturic mesenchymal tumor, mixed connective tissue variant (PMTMCT), through FGFR1c/KL, inducing enhanced FGF23 production by the tumor cells and worsening TIO (Kinoshita et al., 2019).